# Drug Interaction Information in Human Prescription Drug and Biological Product Labeling - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/drug-interaction-information-in-human-prescription-drug-and-biological-product-labeling/8bdf2914-581b-4e86-8a13-dacb0ef306c0 > FDA guidance document: Drug Interaction Information in Human Prescription Drug and Biological Product Labeling. Issue date: October 21, 2024. Get complete insights and analysis. --- ## Details - Title: Drug Interaction Information in Human Prescription Drug and Biological Product Labeling - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2024-10-21 - Comment Close Date: 2025-01-21 - Last Changed: 2024-12-11 - Docket Number: FDA-2024-D-3903 ## Related Documents - [Early Alzheimer’s Disease: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/early-alzheimers-disease-developing-drugs-for-treatment/ef0ff9a7-7208-4951-acbb-acb9937f83e7) - [Geriatric Information in Human Prescription Drug and Biological Product Labeling Guidance for Industry: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/geriatric-information-in-human-prescription-drug-and-biological-product-labeling-guidance-for-industry-draft-guidance-for-industry/bc558261-75a7-4f5d-a91c-5d632df2642a) - [Product Title and Initial US Approval in the Highlights of Prescribing Information for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/product-title-and-initial-us-approval-in-the-highlights-of-prescribing-information-for-human-prescription-drug-and-biological-products-content-and-format-guidance-for-industry/e7792ae4-c049-4de1-bf07-f0bf1ff29121)